For example, in the SELECT cardiovascular outcome trial studying people with obesity, the extent of weight loss did not correlate with the effects of the drug to reduce heart attack, stroke, and cardiovascular death . Also, another long-acting GLP-1 therapy, albiglutide, [was] withdrawn from the market owing to modest efficacy for reduction of glucose and body weight in people with T2D
In 2006, as part of a larger revision, the Green Frog was removed from Rana and assigned to Lithobates , touching off a lively debate on whether the revision was justified and whether Lithobates should be recognized as a genus or as a subgenus within Rana
What Patients Need to Know Side effects: Similar to other GLP-1 drugsmostly nausea, vomiting, or digestive upset
doi: 10.1016/j.ejphar.2024.176905 34 SueyoshiMWatanabeHGotoMSatoTHashimotoMOkiMet al
Semaglutide for managing overweight and obesity Recommendations chapter (TA875)